Rights and permissions
About this article
Cite this article
Teverelix has potential for prostate cancer. Inpharma Wkly. 1605, 10 (2007). https://doi.org/10.2165/00128413-200716050-00023
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200716050-00023